Chihao Zhao
AstraZeneca (Brazil)(BR)AstraZeneca (United States)(US)
Publications by Year
Research Areas
MicroRNA in disease regulation, Cancer-related molecular mechanisms research, Immunotherapy and Immune Responses, RNA modifications and cancer, CAR-T cell therapy research
Most-Cited Works
- → A phenotypic signature that identifies neoantigen-reactive T cells in fresh human lung cancers(2022)179 cited
- → miR-143 and miR-145 synergistically regulate ERBB3 to suppress cell proliferation and invasion in breast cancer(2014)173 cited
- → Effective detection and quantification of dietetically absorbed plant microRNAs in human plasma(2015)171 cited
- → The Jun/miR-22/HuR regulatory axis contributes to tumourigenesis in colorectal cancer(2018)136 cited
- → Biogenesis and function of extracellular miRNAs(2019)124 cited
- → MiR-143 and MiR-145 Regulate IGF1R to Suppress Cell Proliferation in Colorectal Cancer(2014)120 cited
- → miR-96 promotes cell proliferation, migration and invasion by targeting PTPN9 in breast cancer(2016)111 cited
- → miR-181b functions as an oncomiR in colorectal cancer by targeting PDCD4(2016)65 cited
- → microRNA-200b and microRNA-200c promote colorectal cancer cell proliferation via targeting the reversion-inducing cysteine-rich protein with Kazal motifs(2015)64 cited
- → Characterization of a novel panel of plasma microRNAs that discriminates between Mycobacterium tuberculosis infection and healthy individuals(2017)61 cited